Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by OM1

OM1 to Present Groundbreaking Research on GLP-1 Agonists and Suicidal Ideation at ISPOR 2025
From OM1
Via Business Wire
OM1 Adds 1 Million Patients to Its Mental Health Network, Significantly Expanding Specialty Coverage and Driving New Possibilities for Real-World Research and Personalized Care
From OM1
Via Business Wire
OM1 Expands into Europe to Strengthen Support for Life Sciences with AI-Driven Real-World Evidence Solutions
From OM1
Via Business Wire
OM1 Appoints Catherine Richards as President
From OM1
Via Business Wire
OM1 Contributes to Alzheimer’s Disease Research With New PremiOM Dataset of Over 1 Million Patients
From OM1
Via Business Wire
OM1, a Pioneer in Patient Registries, Launches Its Registries Center of Excellence
From OM1
Via Business Wire
OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicine
From OM1
Via Business Wire
OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis
From OM1
Via Business Wire
OM1 to Present Research on Multiple Sclerosis at ACTRIMS Forum 2024
From OM1
Via Business Wire
OM1 Launches Asthma and Chronic Rhinosinusitis Datasets to Expand Real-World Evidence in Respiratory and ENT
From OM1
Via Business Wire
OM1 Launches Hidradenitis Suppurativa Dataset to Expand Real-World Evidence in Dermatology
From OM1
Via Business Wire
OM1 Appoints Shawn Bates as Chief Commercial Officer
From OM1
Via Business Wire
OM1 Launches Parkinson’s Disease Premium Dataset to Expand Real-World Evidence in Neuroscience
From OM1
Via Business Wire
OM1 to Expedite and Improve Research With New Study Automation Platform & Evidence Generation Solution
From OM1
Via Business Wire
OM1 Launches Analytics to Deliver Mental Health & Immunology Insights on Prescriber Trends and Therapy Effectiveness
From OM1
Via Business Wire
OM1 Doubles Lupus Dataset, Representing More Than 56,000 Patients Prospectively Followed With Deep Clinical Data
From OM1
Via Business Wire
OM1 Unveils Patented, AI-powered Platform to Accelerate Personalized Medicine
From OM1
Via Business Wire
OM1 Expands Mental Health Offering With Real-World Datasets Including Schizophrenia and Bipolar Disorder
From OM1
Via Business Wire
OM1 Launches Analytic Reports Uncovering Causes of Medication Discontinuation in Immunology Patients
From OM1
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.